INS and ischemia: Based on in vitro and in vivo analysis it was shown that miR-19a-3p directly targets and inhibits expression of IGFBP3, the gene encoding one of the insulin-like growth factors, and thus induce inflammation and apoptosis processes related to ischemia/reperfusion brain injury.